 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)物質(zhì) > 農(nóng)殘標(biāo)準(zhǔn)物質(zhì) > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：V099502 |
| 產(chǎn)品名稱：Vatalanib-d4 Dihydrochloride |
| 產(chǎn)品CAS：1246820-27-8 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
V099502 |
| 名稱: |
Vatalanib-d4 Dihydrochloride |
| 別名: |
N-(4-Chlorophenyl-d4)-4-(4-pyridinylmethyl)-1-phthalazinamine Dihydrochloride; CGP-79787-d4; |
| CAS號(hào): |
1246820-27-8 |
| 參考CAS號(hào): |
類似: 212141-51-0 |
| 分子式: |
C??H??D?Cl?N? |
| 外觀: |
Light Pink to Pink Solid |
| 熔點(diǎn): |
>201ºC (dec.) |
| 分子量: |
423.76 |
| 儲(chǔ)存: |
Hygroscopic, 冰箱, under inert atmosphere |
| 溶解度: |
Methanol (Slightly), Water (Slightly) |
| 穩(wěn)定性: |
Hygroscopic |
| 類別: |
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Labelled Vatalanib. Vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor. Antineoplastic. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
|
|
